These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10025377)

  • 1. Phase II study of carboplatin and etoposide as salvage treatment for patients with metastatic breast cancer.
    Ron IG; Vishne TH; Kraminsky N; Bar-Am A; Inbar MJ
    Am J Clin Oncol; 1999 Feb; 22(1):35-7. PubMed ID: 10025377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of carboplatin and etoposide activity in pretreated breast cancer patients.
    Viñolas N; Daniels M; Estapé J; Grau JJ; Palombo H; Solá C
    Am J Clin Oncol; 1992 Apr; 15(2):160-2. PubMed ID: 1553906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of carboplatin and VP-16 for patients with metastatic breast cancer and only one prior chemotherapy regimen.
    Barker LJ; Jones SE; Savin MA; Mennel RG
    Cancer; 1993 Aug; 72(3):771-3. PubMed ID: 8334629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of carboplatin and etoposide in metastatic breast cancer.
    Crown J; Hakes T; Reichman B; Lebwohl D; Gilewski T; Surbone A; Currie V; Yao TJ; Hudis C; Seidman A
    Cancer; 1993 Feb; 71(4):1254-7. PubMed ID: 8435802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.
    Recchia F; Nuzzo A; Lalli A; De Filippis S; Torchio P
    Am J Clin Oncol; 1997 Apr; 20(2):166-8. PubMed ID: 9124193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intensive chemotherapy in the treatment of patients with metastatic breast cancer].
    Salgado JE; Aramendía JM; Fernández-Hidalgo OA; Lozano E; Rebollo J; Martínez-Monge R; Subirá ML; Brugarolas A
    Rev Med Univ Navarra; 1997; 41(3):143-51. PubMed ID: 10420919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.
    Mavroudis D; Alexopoulos A; Malamos N; Ardavanis A; Kandylis C; Stavrinidis E; Kouroussis Ch; Agelaki S; Androulakis N; Bozionelou V; Georgoulias V
    Oncology; 2003; 64(3):207-12. PubMed ID: 12697959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
    van der Gaast A; Bontenbal M; Planting AS; Kok TC; Splinter TA
    Ann Oncol; 1994 Nov; 5(9):858-60. PubMed ID: 7661927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.
    Chang AY; Hui L; Asbury R; Boros L; Garrow G; Rubins J
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S26-8. PubMed ID: 10602907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
    Kim R; Osaki A; Tanabe K; Kojima J; Toge T
    Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
    Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
    Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results.
    Baker WJ; Vukelja SJ; Burrell LM; Lee N; Perry JJ
    Bone Marrow Transplant; 1998 Apr; 21(8):775-8. PubMed ID: 9603400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
    Chauvergne J; Chinet-Charrot P; Stöckle E; Thomas L; Toulouse C
    Bull Cancer; 1996 Apr; 83(4):315-23. PubMed ID: 8680083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.
    Fountzilas G; Skarlos D; Theoharis D; Giannakakis T; Stathopoulos G
    Tumori; 1993 Dec; 79(6):389-92. PubMed ID: 8171736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
    deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
    Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
    Beddoe AM; Dottino PR; Cohen CJ
    Mt Sinai J Med; 1993 Sep; 60(4):311-6. PubMed ID: 8232377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.